Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iMedrix is a private digital health and medical device company focused on mobile cardiology and remote cardiac diagnostics. Its flagship product, KardioScreen, is a cloud-connected, FDA-cleared medical-grade 12/6-lead ECG solution designed to help clinicians diagnose and manage cardiac abnormalities at the bedside or remotely. The company positions its technology as a patient-centric platform intended to expand access to cardiac care, including in underserved and out-of-hospital settings. iMedrix combines hardware, cloud connectivity, and digital workflow capabilities rather than developing therapeutics. The business appears to operate across the United States, India, and Singapore, with activities spanning product development, commercialization, and support for cardiovascular care providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iMedrix.